We only have this paper's title and publication details.
Read it at the sourceThis clinical trial links altered brain areas to metabolic decline in individuals with Alzheimer's disease biomarkers, suggesting early brain changes in the disease process.
EudraCT:2016-002,441-36; IDRCB:2016-A01767-44; ClinicalTrials.gov Identifier: NCT02977819.
No takes yet. Share an insight, caveat, or question.
Foyard et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: